Search results
2 lut 2023 · Adoptive cell transfer (ACT), an immunotherapy that harnesses the patient’s immune cells or those of a healthier donor to combat cancer, has currently emerged as a crucial component of cancer treatment.
11 lis 2021 · A combination consisting of the ICI atezolizumab and the anti-angiogenic agent bevacizumab is the first treatment regimen that has been shown to improve overall survival in patients with...
Immunotherapy is the use of medicines that help a person’s own immune system find and destroy cancer cells. It can be used to treat some people with liver cancer.
29 lut 2024 · Key points. Approximately 30% of patients with hepatocellular carcinoma (HCC) undergo resection or local ablation as primary treatment. However, the probability of recurrence at 3 years is...
Tematy dnia
4 paź 2020 · Application of immunotherapy regimens in patients with HCC has led to encouraging results in terms of both safety and efficacy. In this review, we summarize the key points of currently available clinical trials and immunotherapy perspectives for HCC.
Immunotherapy drugs have shown impressive results in the treatment of specific immunogenic cancers, prompting the possibility of their use in liver cancers. Immunotherapy medications approved for other cancers have received FDA accelerated approval for treatment of hepatocellular carcinoma.
13 kwi 2021 · Key points. Multiple immune mechanisms are important in the development and progression of hepatocellular carcinoma (HCC) and correlate with prognosis. Checkpoint inhibitors targeting PD1 and...
